Nov. 14 (UPI) -- OxyContin-maker Purdue Pharma can settle claims against it by paying up to $7.4 billion to end cases filed amid the nation's opioid epidemic, a federal bankruptcy judge ruled Friday.
The proposed settlement is $1 billion more than one recently rejected last year by the Supreme Court and includes payments to individuals to end some 2,600 claims against Purdue Pharma and its principal owners, the Sackler family, the BBC reported.
"Today cements the end of a long chapter and brings us very near to the end of the book for Purdue," Purdue Pharma Chairman Steve Miller said Friday in a prepared statement.
The court-approved settlement would "unlock billions in recoveries and significant non-monetary benefits," he added.
Related
